Literature DB >> 9843361

Clinical and molecular heterogeneity of familial hyperinsulinism.

B Glaser, P S Thornton, K Herold, C A Stanley.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9843361     DOI： 10.1016/s0022-3476(98)70160-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

Review 1.  Practical management of hyperinsulinism in infancy.

Authors:  A Aynsley-Green; K Hussain; J Hall; J M Saudubray; C Nihoul-Fékété; P De Lonlay-Debeney; F Brunelle; T Otonkoski; P Thornton; K J Lindley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.

Authors:  Pei-Chun Chen; Erik M Olson; Qing Zhou; Yelena Kryukova; Heidi M Sampson; David Y Thomas; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

3.  Genetic association and functional analysis of rs7903456 in FAM35A gene and hyperuricemia: a population based study.

Authors:  Feng Yan; Peng Sun; Huishou Zhao; Changhai Zhao; Nana Zhang; Yujie Dai
Journal:  Sci Rep       Date:  2018-06-25       Impact factor: 4.379

4.  Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations.

Authors:  Samir Sayed; David R Langdon; Stella Odili; Pan Chen; Carol Buettger; Alisa B Schiffman; Mariko Suchi; Rebecca Taub; Joseph Grimsby; Franz M Matschinsky; Charles A Stanley
Journal:  Diabetes       Date:  2009-03-31       Impact factor: 9.461
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.